Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Michigan for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Michigan only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Michigan (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

George Murakawa (NPI 1265422497)

Field	Value
Entity Type	Individual
Organization	George Murakawa
Address	255 Kirts Blvd
City	Troy
State	MI
ZIP	48084
Taxonomy	Dermatology Physician
NPI Enumerated	October 27, 2005

Payer Source	Total Paid
Medicare	$2.1M
Medicaid	$0

Key Findings

This provider is a dermatology physician with a combined medical and procedural practice pattern: the top codes include high-cost biologic injections (J3245, J2357), Mohs surgery series (17311, 17312, 17313), and high-volume lesion destruction and biopsy codes (17000, 17003, 11104). The code mix implies ongoing in-office administration of biologic therapies alongside a robust surgical dermatology service line that performs excisions, reconstructions, and numerous biopsies and lesion destruction procedures.

Medicare is the sole payer on file: total Medicare revenue is reported as $2.1M and there is no Medicaid billing on file. This effectively makes the practice single-payer on the public side and concentrates public-revenue exposure to Medicare reimbursement trends and coverage policies for biologics and procedural dermatology.

Revenue concentration is high: the precomputed top-3 Medicare codes account for 51.1% of the provider's Medicare revenue, with J3245 alone contributing $682.2K (33.5% of Medicare revenue). That concentration indicates material dependence on a small set of high-revenue services—notably tildrakizumab administration—so formulary changes or drug-pricing adjustments for these therapies could materially affect overall Medicare revenue.

Competitive standing is mixed across codes: for J3245 the provider ranks #45 of 225 nationally (80th percentile; typical, unremarkable volume), and for J2357 ranks #192 of 581 (67th percentile; typical, unremarkable volume), indicating moderate, non-dominant national presence in biologic administration. By contrast, the provider is a clear national high-volume outlier on several procedural and evaluation codes—for example 11104 ranks #6 of 6872 (100th percentile; extreme outlier) and 99213 ranks #1738 of 457151 (100th percentile; extreme outlier)—which signals strong procedural throughput relative to peers.

Several procedural codes show unusually high activity versus national peers and are flagged with extreme or notable outlier language: 17003 is ranked #32 of 19643 (100th percentile; extreme outlier), 17000 is #187 of 21879 (99th percentile; extreme outlier), and 11105 is #8 of 985 (99th percentile; extreme outlier). These patterns point to exceptionally high volumes of lesion-destruction/add-on lesion work and multiple punch biopsies per encounter compared with the national dermatology population, suggesting workflow and resource needs (supplies, pathology throughput) aligned to high lesion-count visits.

The practice generates meaningful revenue from Mohs and reconstruction codes as well: 17311 accounts for $161.6K (7.9% of Medicare revenue) and related Mohs codes 17312 and 17313 also contribute materially. Mohs ranks are middle-tier nationally (e.g., 17311 at #830 of 2969, 72th percentile; typical, unremarkable volume), indicating the provider performs a steady but not nationally dominant Mohs surgery volume consistent with an established surgical dermatology offering.

Operational implications for payers and network managers include managing biologic drug reimbursement and monitoring high-volume ancillary services: substantial revenue from J3245 and J2357 suggests contract clauses, prior authorization processes, and drug-acquisition oversight will be particularly relevant. Simultaneously, the provider’s extreme-volume biopsy and lesion-destruction activity implies significant downstream pathology and procedure utilization that can drive utilization-management and cost-containment discussions.

Tenure and stability: the NPI was enumerated on 2005-10-27 (~21 years ago), indicating a long-established practice in Troy, MI. That tenure, combined with the observed code mix and high procedural volumes, suggests an entrenched local provider with mature operational patterns rather than a recently established clinic.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

48 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J3245	Injection, tildrakizumab, 1 mg	6,200	$110	$682.2K
J2357	Injection, omalizumab, 5 mg	6,600	$30	$198K
17311	Mohs surgery is a multi–staged procedure that is performed to excise a malignant lesion layer by layer, along with histo–pathological assessment. The assessment is performed to ensure that the…	400	$400	$161.6K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	1,610	$70	$106.4K
17312	Mohs surgery is a multi–staged method of excising a malignant lesion layer by layer, along with histo–pathological assessment, to ensure negative malignancy of the margins.	280	$340	$93K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	890	$100	$84.9K
17313	Mohs surgery is a multi–staged method of excising a malignant lesion layer by layer, along with histo–pathological assessment, to ensure negative malignancy of the margins.	140	$470	$66.5K
17000	The provider destroys a premalignant lesion using techniques such as chemosurgery, cryosurgery, electrosurgery, or others. This code reports the destruction of the first or only lesion.	1,610	$40	$66K
14301	The provider replaces the lesions in any area with the healthy tissues from an adjacent site. This code represents a defect of 30.1 cm2 to 60.0 cm2.	70	$880	$65K
96910	The provider applies tar or petrolatum to the skin and exposes the area to ultraviolet B, or UVB, rays to treat certain skin diseases such as psoriasis.	710	$90	$60.5K

Showing 1–10 of 48

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 48 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Michigan Distribution

George Murakawa — 15 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Michigan

Full comparison — all codes billed, vs. state median

48 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J3245	1	10	3,900	$110	$391.8K
J2357	7	10	6,600	$30	$222.2K
17311	13	70	150	$440	$98.2K
17312	9	60	90	$300	$41K
14302	3	10	190	$180	$33.6K
14301	3	20	20	$810	$30.8K
96910	2	10	180	$80	$25.2K
88305	165	470	440	$30	$23.1K
17313	1	50	30	$430	$20K
14041	1	20	20	$700	$19K

Showing 1–10 of 48

Nearby Providers

Other providers in the same ZIP code as George Murakawa, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Integra Partners LLC	MI	Customized Equipment (DME)	$0	$422.5M
The Arc Of Oakland County, Inc	MI	Voluntary or Charitable Agency	$0	$171.1M
Bower Enterprises Inc	MI	Community/Behavioral Health Agency	$0	$59.2M
Behavioral Outcomes Management,llc	MI	Community/Behavioral Health Agency	$0	$48.8M
Integra Partners Ipa (florida), LLC	MI	Durable Medical Equipment & Medical Supplies	$0	$27.5M
Vpa PC	MI	Family Medicine Physician	$0	$19.2M
Vpa PC	MI	Clinical Medical Laboratory	$4.6M	$8.1M
Lahser Pre-vocational Centers, Inc.	MI	Developmentally Disabled Services Day Training Agency	$0	$9.6M
Quality Choice Home Healthcare Inc.	MI	Home Health Agency	$0	$6.6M
Dental Associates Ii PC	MI	Dentist	$0	$6.5M

George Murakawa — Billing Profile & Reimbursement Data

Sign up for George Murakawa — Billing Profile & Reimbursement Data policy alerts

George Murakawa — Billing Profile & Reimbursement Data

Sign up for George Murakawa — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Nearby Providers

Frequently Asked Questions

References